GPBAR1 and hepatocellular carcinoma: The methylation of the TGR5 promoter is significantly more frequent in HCC than in chronic hepatitis B, and the hypermethylated TGR5 serum cell-free DNA promoter may serve as a biomarker for HCC surveillance (Han et al., 2014).